ASPIRE Community of Practice (@ASPIRE_CoP) header
ASPIRE Community of Practice (@ASPIRE_CoP) profile picture
United States
Joined April 2025
Photo by ASPIRE Community of Practice (@ASPIRE_CoP)Photo by ASPIRE Community of Practice (@ASPIRE_CoP)Photo by ASPIRE Community of Practice (@ASPIRE_CoP)Photo by ASPIRE Community of Practice (@ASPIRE_CoP)Photo by ASPIRE Community of Practice (@ASPIRE_CoP)Photo by ASPIRE Community of Practice (@ASPIRE_CoP)Photo by ASPIRE Community of Practice (@ASPIRE_CoP)Photo by ASPIRE Community of Practice (@ASPIRE_CoP)Photo by ASPIRE Community of Practice (@ASPIRE_CoP)Photo by ASPIRE Community of Practice (@ASPIRE_CoP)
🩺 Join ASPIRE’s irAE case discussion on Tue, Nov 17, 5:30 PM CT, with Drs. Michael Jain (Moffitt) & Rafeh Naqash (OU), moderated by Drs. Bryan Schneider (UMich) & Lucy Boyce Kennedy (Cleveland Clinic). CME available 👉 tinyurl.com/u93a98fz #irAE @MichaelDJain @thenasheffect
2
4
227
👏 Welcome to the newest members of the #irAE Challenging Case Discussion Planning Committee: Dr. Pankti Reid (UChicago, Rheum), Dr. Melissa Lechner (UCLA, Endo) & Dr. Kriti Mittal (UMass, Onc). @ReidMDMPH @MelissaGLechner @KMittalmd
1
55
ASPIRE Community of Practice retweeted
A passion project of the indomitable #AungNaing, editor-in-chief of @JIPOEditors, was just published! An honor to be part of this ambitious effort discussing barriers and opportunities in ICI therapy today! Authors from @UTMDAnderson @DanaFarberNews @UCSF @BrownUniversity & more
Hot off the press! In this new #JIPO publication, Drs Joud Hajjar, Bettzy Stephen, Aung Naing, and colleagues synthesize key barriers in #ICI therapy and highlight emerging opportunities to refine patient selection, improve safety, and enhance therapeutic durability. Together, these advances position the field to move toward a more precise, effective, and patient-centered era of immuno-oncology. Note: Journal-based #CME is available for reading this article via InnoScholar.com Article: doi.org/10.36401/JIPO-26-12 CME activity: innoscholar.com/course/jipo-… #PositionPaper #ICItherapy #irAEs #immunotherapy #precisiononcology #biomarkers #journalCME @HajjarJoud @BettzyStephen @ajaysheshadri @kjazieh @ANaingMD @SewantiLimaye @jibranahmed1 @weoncologists @MDerbalaMD @mirella_nardo @ErulEnes @IMENEHADJI1 @RegmiSunil1 @OncologyNetwork @Innovativehci @InnoScholars @oncodaily @OncoAlert
7
16
1,152
Our November @sitcancer special edition 📰newsletter is out! mailchi.mp/3cf0718a5f0d/f9hi… Bonus feature: Check out this list of curated abstracts to watch for as you head into the 41st Annual @sitcancer meeting in Phoenix this weekend 🔗⬇️ mailchi.mp/3cf0718a5f0d/f9hi…
1
322
🎥 A first for ASPIRE: a patient speaker! In our Sept webinar, Mike shared his irAE journey, Dr. Laura Petrillo (MGB) presented UPLIFT & Dr. Matthias Villalobos (Heidelberg) spoke on shared decision-making. Watch on myConnection 👉 myconnection.asco.org/ #irAE
1
86
Missed #ESMO26? We rounded up the immunotoxicity highlights from Madrid: novel biomarkers, risk prediction models, new management strategies & challenging cases. Catch up in the latest ASPIRE newsletter!  #irAE
2
1
1
378
ASPIRE Community of Practice retweeted
Congratulations to our team @ASPIRE_CoP for starting this special interest group @sitcancer See our latest newsletter to learn about the upcoming get together at the annual @sitcancer meeting
Connect with SITC members who share your scientific interests! Explore SITC’s three active Special Interest Groups (SIGs): ASPIRE, Peri-IO Safety and Microbiome. Discover opportunities to network, collaborate and advance cancer immunotherapy. Learn more: sitcancer.org/get-involved/s…
2
1
4
414
ASPIRE Community of Practice retweeted
Drs Andrew Trinh and Sophia Ling are fantastic gastroenterology colleagues @PeterMacCC Thanks so much for helping @NzsOncology put together this free irAE webinar series 🤩 great resource! @MOGA_ORG @ONCOassist @OncoAlert @ASPIRE_CoP @IndianYoungOnco @oncodaily
The latest of our #NZSOimmunotoxwebinar series is now available online as a FREE resource for any to use and reference! Share widely amongst colleagues 👉nzsoncology.org.nz/webinarse…
1
4
13
458
🎉 Big news! The new ASPIRE Special Interest Group at #SITC26 holds its first in-person meet-up. 📅 Nov 7, 7:10–7:40 PM at the SITC booth in Phoenix. 🌵 Come connect, share ideas & help build the SIG. Appetizers & drinks on us! 🍽️ #irAE #immunotherapy @KMittalmd @sitcancer
2
3
376
ASPIRE, a community of practice of @ASCO is proud to present a virtual webinar on Elevating Patient Voices in the Management of irAEs. Join us today at 4 pm EST for our Quarterly Webinar series with hosts @KMittalmd and @afreenshariffmd 🔗 in flyer ⬇️
📢 ASPIRE Quarterly Webinar Elevating Patient Voices & Management of #irAEs 📆 Tues 9/22 · 4:00–5:30 PM ET 🎤 Drs. Laura Petrillo @lpetrillz, Jasmin Tiro, Matthias Villalobos 🎯 Moderated by Drs. @KMittalmd & @afreenshariffmd 💻 Zoom🔗: us.list-manage.com/1B14TXB1R… #Oncology
1
2
155
📢 ASPIRE Quarterly Webinar Elevating Patient Voices & Management of #irAEs 📆 Tues 9/22 · 4:00–5:30 PM ET 🎤 Drs. Laura Petrillo @lpetrillz, Jasmin Tiro, Matthias Villalobos 🎯 Moderated by Drs. @KMittalmd & @afreenshariffmd 💻 Zoom🔗: us.list-manage.com/1B14TXB1R… #Oncology
1
1
2
328
Residents & fellows: how are you learning about immune-related adverse events? ⏱️ 5 minutes 🔒 Anonymous ✅ No right or wrong answers Help ASPIRE's Community Education Committee build better irAE education 👇
1
2
6
843
🚨 Aug 18: ASPIRE case discussion on immunotherapy toxicity 🧠 Neuro — John Probasco, MD (Hopkins) 🩹 Skin — Silvina Pugliese, MD (NYU) Moderators: Aliyah Pabani, MD & Stephane Champiat, MD, PhD 5:30–6:30 PM CST | CME 51508 tinyurl.com/yck5afku #irAE #Oncology @KMittalmd
1
1
1
1
1,180
In case you missed this- link will be in our upcoming newsletter- stay tuned!
20
ASPIRE Community of Practice retweeted
Replying to @ASPIRE_CoP
@ASPIRE_CoP members please take note!
🚨irAE aficianados! Open comment for Renal, Musculoskeletal, and Cardiac adverse events sections of the @ASCO irAE guidelines are now available through August 28th at: asco1.qualtrics.com/jfe/form… As everything with irAE, it's a team sport. We want to hear your comments!
1
1
310
Please share with your trainees- to help us design evidence based education pertaining to irAEs. cc: @DrKarineTawagi @ASridharMD @NazliDizman @FunchainMD @PGrivasMDPhD
2
1
5
1,642
Happening now- join us for our quarterly webinar!
2
120
⏰ Starting in 15 minutes! Join ASPIRE's webinar "ASCO Highlights in irAEs: Key Abstracts & Clinical Takeaways" — 4 PM EST with our expert panel. Hop on 👉 shorturl.at/B2zt2 #irAE #immunotherapy #oncology
2
85
Glad to see some of our Executive Committee members on this- @ASPIRE_CoP remains committed to fostering a community of #irAE clinicians, educators and researchers! @FunchainMD @thenasheffect
Today's @sitcancer program on immunotherapy toxicity management felt less like a webinar and more like a conversation among colleagues. #irAEs remain one of the areas where clinical experience is often ahead of the evidence, making discussions like these particularly valuable. A pleasure to share the session with such a great faculty panel and many friends across the field. @kreynoldsMD @thenasheffect @EladSharonMD @FunchainMD @LKottschadeCNP Ryan Sullivan, Matthew Lei, Aleksandra Kukla. Thanks to @sitcancer for the invitation and the discussion! @Surgeon_General @CampusBioMedico @PoliclinCampus
1
1
4
464